LiComm Co., Ltd. (KOSDAQ:388790)
5,460.00
-480.00 (-8.08%)
At close: May 14, 2026
LiComm Revenue
In the year 2025, LiComm had annual revenue of 17.69B KRW with 34.65% growth. LiComm had revenue of 8.13B in the quarter ending December 31, 2025, with 83.92% growth.
Revenue
17.69B
Revenue Growth
+34.65%
P/S Ratio
9.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
167.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.69B | 4.55B | 34.65% |
| Dec 31, 2024 | 13.14B | -6.33B | -32.50% |
| Dec 31, 2023 | 19.46B | -14.87B | -43.31% |
| Dec 31, 2022 | 34.33B | 6.30B | 22.48% |
| Dec 31, 2021 | 28.03B | -2.57B | -8.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KG Financial | 233.77B |
| Daihan Pharmaceutical | 208.61B |
| Paseco Co. | 167.91B |
| S&D Co., Ltd | 150.94B |
| Synergy Innovation | 113.05B |
| SHINHWA PRITECH | 107.78B |
| Innotech | 75.70B |
| Vivozon Pharmaceutical | 59.34B |